FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086271 [Registered on: 05/05/2025] Trial Registered Prospectively
Last Modified On: 04/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study of mutraja vikrita kleda and efficacy of Katak beeja churna in diseases like diabetes melllitus and chronic renal failure with special reference to routine urine examination. 
Scientific Title of Study   A clinical study of mutraja vikrita kleda and efficacy of Kataka beeja churna with special reference to routine urine examination. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Dhanwantari Behera 
Designation  PG Scholar 
Affiliation  Govt Ayurvedic College And Hospital Guwahati Assam 
Address  Dept of Roga Nidan Govt Ayurvedic College And Hospital Ghy14 Assam

Kamrup
ASSAM
781014
India 
Phone  8144719750  
Fax    
Email  kdhani1207@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anup Baishya 
Designation  Professor Head of Department and Guide 
Affiliation  Govt Ayurvedic College And Hospital Guwahati Assam 
Address  Dept of Roga Nidan Govt Ayurvedic College And Hospital Ghy14 Assam

Kamrup
ASSAM
781014
India 
Phone  8638211711  
Fax    
Email  baishya.anup.815@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anup Baishya 
Designation  Professor Head of Department and Guide 
Affiliation  Govt Ayurvedic College And Hospital Guwahati Assam 
Address  Dept of Roga Nidan Govt Ayurvedic College And Hospital Ghy14 Assam

Kamrup
ASSAM
781014
India 
Phone  8638211711  
Fax    
Email  baishya.anup.815@gmail.com  
 
Source of Monetary or Material Support  
GOVT AYURVEDIC COLLEGE AND HOSPITAL GHY14 
 
Primary Sponsor  
Name  Dr Dhanwantari Behera 
Address  Dept of Roga Nidan Govt Ayurvedic College And Hospital Jalukbari GHY14 Assam 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
CCRAS  Central Council for Research in Ayurvedic Sciences D Block Janakpuri Institutional Area Janakpuri New Delhi 110058 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Dhanwantari Behera  Govt Ayurvedic College And Hospital Jalukbari Assam  OPD and IPD of Dept.of Roganidan,Govt Ayurvedic College And Hospital Ghy14 Assam
Kamrup
ASSAM 
08144719750

kdhani1207@gmail.com 
Dr Dhanwantari Behera  INSTITUTE OF ADVANCED STUDY IN SCIENCE AND TECHNOLOGY  VIGYAN PATH GARCHUK PASCHIM BORAGAON
Kamrup
ASSAM 
08144719750

kdhani1207@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, Govt Ayurvedic College and Hospital,Jalukbari, Guwahati  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E112||Type 2 diabetes mellitus with kidney complications. Ayurveda Condition: PRAMEHA-UPADRAVAH, (2) ICD-10 Condition:N189||Chronic kidney disease, unspecified. Ayurveda Condition: MUTRAVAHASROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Katak Beej, Reference: Yoga Ratnakar,Prameha Rogadhikar, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Takra/Madhu), Additional Information: -Churna of Katak beej will be grinded with Takra then taken with Madhu
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patients within the age of 18 to 70 years of both sexes having symptoms of Mutraja Vikrita Kleda will be taken.
2. All the selected patients who well give their consent for clinical study will be included.

3. Patient with diagnosed case of chronic renal failure (CRF) with proteinuria

4. Patient with clinical symptoms of diabetic nephropathy.


 
 
ExclusionCriteria 
Details  1. Patients below 18 years and above 70 years, pregnant women and lactating mother.
2. Complicated chronic renal failure patients.
3. Patient with Sr. Creatinine more than 6mg/dl
4. Patient with the other systemic complication where needs other intervention.
5. Patient with systemic diseases and immunocompromised states like HIV, TB, Hepatitis B, Hepatitis C
6. Patients with malignancy
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the effect of Kataka beeja churna in mutraja vikrita kleda includes diseases like diabetes mellitus with nephropathy and chronic renal failure without diabetes mellitus.  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
An invitro study will be conducted to see the nephroprotective effect of Katak beej.  08 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   17/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a clinical study of Kataka beeja churna in the management of mutraja vikrita kleda where 2 groups of diseases will be taken namely chronic renal failure with diabetic nephropathy and chronic renal failure without diabetes mellitus.This study has also includes the objective to find the relation between mutraja vikrita kleda with the abnormalities of urine.Also an in vitro study is done to see the nephroprotective effect of Katak beej.This study is done as a mandatory post graduation thesis work.Total no of patients will be 60 to be studied for 45 days. 
Close